Evenity and Bone density abnormal - a phase IV clinical study of FDA data
Summary:
Bone density abnormal is reported as a side effect among people who take Evenity (romosozumab-aqqg), especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years also take Prolia, and have Osteoporosis post-menopausal.
The phase IV clinical study analyzes which people have Bone density abnormal when taking Evenity. It is created by eHealthMe based on reports of 9,472 people who have side effects when taking Evenity from the FDA, and is updated regularly.
What is Evenity?
Evenity has active ingredients of romosozumab-aqqg. eHealthMe is studying from 9,485 Evenity users. Check the latest studies of Evenity.
What is Bone density abnormal?
Bone density abnormal is found to be associated with 247 drugs and 252 conditions by eHealthMe. Check the latest studies of Bone density abnormal.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
9,472 people reported to have side effects when taking Evenity.
Among them, 437 people (4.61%) have Bone density abnormal.
Among these 437 people:
How long have people been on Evenity when they have Bone density abnormal? *
What is the gender of people who have Bone density abnormal when taking Evenity? *
What is the age of people who have Bone density abnormal when taking Evenity? *
What are other drugs people take besides Evenity? *
What are other side effects people have besides Bone density abnormal? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Evenity and have Bone density abnormal?
- Check whether Bone density abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Evenity:
- Evenity (9,485 reports)
Bone density abnormal treatments and more:
- Bone density abnormal (7,126 reports)
How severe was Bone density abnormal and when was it recovered:
Expand to all the drugs that have ingredients of romosozumab-aqqg:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Evenity:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Bone density abnormal:
- Bone density abnormal (247 drugs)
Browse all the conditions that are associated with Bone density abnormal:
- Bone density abnormal (252 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on romosozumab-aqqg (the active ingredients of Evenity) and Evenity (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Focalin and Luvox - 4 seconds ago
- Burkitt Lymphoma and Muscle Aches - 5 seconds ago
- Could Biaxin cause C-Reactive Protein Increased? - 7 seconds ago
- Could Biaxin cause Bronchial Secretion Retention? - 9 seconds ago
- Breast Cancer Aggravated and Movement - Uncoordinated - 13 seconds ago
- Asthma Aggravated and Nasal Congestion - 20 seconds ago
- Could Pulmicort cause Developmental Delay? - 28 seconds ago
- Metformin and Stiff Neck for Women aged 60+ - 33 seconds ago
- Could Makena cause Weakness? - 33 seconds ago
- Metformin and Pain - Neck for Women aged 60+ - 33 seconds ago